PORTAGE, Mich.--(BUSINESS WIRE)--Stryker (NYSE:SYK), a global leader in medical technologies, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Incompass® ...
Stryker SYK recently received FDA clearance for its InCompass Total Ankle System, marking a pivotal expansion in the company's Foot & Ankle portfolio. Designed to address end-stage ankle arthritis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results